Jon Snodgres - 07 Oct 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
07 Oct 2022
Net transactions value
+$27,736
Form type
4
Filing time
11 Oct 2022, 17:00:08 UTC
Previous filing
17 Aug 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $27,736 +466 +1.4% $59.52 34,972 07 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +466 +28% $0.000000 2,108 07 Oct 2022 Common Stock 466 $59.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of options was effected pursuant to a 10(b)5-1 trading plan adopted on September 6, 2022.
F2 This option is fully vested and exercisable.